I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

AAIC 2025

We will be contributing to topics related to
-
11:30 AM
Duration 9hrs Toronto, Canada
Evaluating the Impact on Diagnostic Performance and Healthcare Resource Utilization of Introducing a plasma rule-out test in the Alzheimer's Disease Diagnostic Pathway
Sophie Roth, Gustaf Ortsäter, Joana Amorim Freire
Duration 9hrs Toronto, Canada
Accuracy of cerebrospinal fluid biomarker ratios to determine amyloid positron-emission tomography status: a diagnostic test accuracy meta-analysis
Pablo Martinez-Lage, Eino Solje, Julian G. Martins, Sraboni Sarkar
Duration 9hrs Toronto, Canada
Investigating Differences in Patients Enrolled in a Clinical Study Based on Referral Type
Sophie Roth, Laura Schlieker, Sayuri Hortsch, Joana Amorim Freire, David Caley
Duration 9hrs Toronto, Canada
GABriella, a Phase 2a study investigating the gamma-secretase modulator RG6289 in individuals at risk for and at the prodromal stage of Alzheimer’s disease: baseline characteristics of the recruited participants
Rosanna Tortelli
Duration 9hrs Toronto, Canada
QUALITY OF RELATIONSHIPS BETWEEN INFORMAL CAREGIVERS AND PATIENTS WITH MILD COGNITIVE IMPAIRMENT
Elena Garcia-Arcelay
06:00 PM
Duration 90mins Room 718
Toward a new era of anti-amyloid antibodies: New mechanism of drug delivery and latest update on trontinemab
Catherine Mummery, Jeffrey L. Cummings, João A. Abrantes, David Agnew, Silke Ahlers, Fabien Alcaraz, Scarlett Barker, Tobias Bittner, Ruth Croney, Paul Delmar, Hideki Garren, Carsten Hofmann, Gregory Klein, Luka Kulic, Christopher Lane, Maddalena Marchesi, Jens Niewoehner, Gil D. Rabinovici, Daria Rukina, Stephen Salloway, Andres Schneider, Denise Sickert, Janice Smith, Reisa A Sperling, Franziska Schaedeli Stark, Hanno Svoboda, Angeliki Thanasopoulou, Matteo Tonietto, Roberto Villaseñor, Iris Wiesel, Jakub Wojtowicz, Stella Yilmaz, Henrik Zetterberg
06:05 PM
Duration 15mins Room 718
Next wave of innovation in Alzheimer’s disease therapeutics: The value of novel active transport mechanisms
Catherine Mummery, Roberto Villaseñor, Jens Niewoehner, Scarlett Barker, Luka Kulic
06:20 PM
Duration 15mins Room 718
Latest results from the dose-expansion part (Part 2) of the Brainshuttle™ AD study of trontinemab in people with Alzheimer’s disease
Luka Kulic, Fabien Alcaraz, Gregory Klein, Stephen Salloway, Carsten Hofmann, João A. Abrantes, Stella Yilmaz, Denise Sickert, Maddalena Marchesi, Jakub Wojtowicz, Andres Schneider, Ruth Croney, David Agnew, Silke Ahlers, Paul Delmar, Hanno Svoboda, Iris Wiesel
06:35 PM
Duration 15mins Room 718
Interim biomarker results for trontinemab, a novel Brainshuttle™ antibody in development for the treatment of Alzheimer’s disease
Gregory Klein, Gil D. Rabinovici, Henrik Zetterberg, Matteo Tonietto, Tobias Bittner, Daria Rukina, Fabien Alcaraz, Carsten Hofmann, Maddalena Marchesi, Jakub Wojtowicz, Ruth Croney, David Agnew, João A. Abrantes, Franziska Schaedeli Stark, Silke Ahlers, Paul Delmar, Hanno Svoboda, Iris Wiesel, Luka Kulic
06:50 PM
Duration 15mins Room 718
TRONTIER 1 and TRONTIER 2: Pivotal trials of trontinemab in early symptomatic Alzheimer’s disease
Janice Smith, Catherine Mummery, Jeffrey L. Cummings, Gil D. Rabinovici, Stephen Salloway, Reisa A Sperling, Henrik Zetterberg, Angeliki Thanasopoulou, Christopher Lane, Paul Delmar, Gregory Klein, Ruth Croney, Jakub Wojtowicz, Carsten Hofmann, Luka Kulic, Hideki Garren
11:30 AM
Duration 9hrs Toronto, Canada
Evaluating the Clinical Performance of the Elecsys pTau217 Plasma Immunoassay to Detect Amyloid Pathology in a Routine Clinical Practice Cohort
Sayuri Hortsch, Niels Borlinghaus, Alexander Jethwa, David Caley, Annunziata Di Domenico, Craig Ritchie
06:00 PM
Duration 90mins Toronto, Canada
Clinical performance and effect of pre-analytical variation of plasma pTau217 alone versus the plasma pTau217/Aβ42 ratio for the identification of amyloid pathology
Christopher M. Rank, Joana Amorim Freire, Alexander Jethwa, Annunziata Di Domenico, Christina Rabe, Marc Suárez-Calvet, Colin L. Masters, Tobias Bittner
11:30 AM
Duration 9hrs Toronto, Canada
Equity in diagnosis through adequate clinical trial design in diagnostic performance studies
Imke Kirste, David Caley, Clara Quijano Rubio, Margherita Carboni
Coming soon